COMPARATIVE EVALUATION OF PAP SMEAR WITH HISTOPATHOLOGY IN CERVICAL LESION ACCORDING TO THE 2014 BETHESDA SYSTEM: AN INSTITUTIONAL STUDY

Authors

  • GOURANGA CHARAN PRUSTY Department of Pathology, S.C.B. Medical College, Cuttack, Odisha, India
  • RANJAN KUMAR MALLICK Department of Pathology, S.C.B. Medical College, Cuttack, Odisha, India
  • GOUTAMI DAS NAYAK Department of Pathology, S.C.B. Medical College, Cuttack, Odisha, India
  • SUNANDA NAYAK Department of Pathology, VIMSAR, Burla, Odisha, India.
  • CHANDRAPRAVA MISHRA Department of Pathology, S.C.B. Medical College, Cuttack, Odisha, India
  • TAPAS RANJAN MISHRA Department of Pathology, VIMSAR, Burla, Odisha, India

DOI:

https://doi.org/10.22159/ajpcr.2024v17i10.52700

Keywords:

The 2014 Bethesda System, Cervical pap smear, Cytology, Histopathology, Diagnostic accuracy

Abstract

Objectives: The objective of this study is to evaluate the efficacy of a pap smear using The 2014 Bethesda System (TBS) for the diagnosis of premalignant and malignant lesions of the uterine cervix.

Methods: A prospective study was conducted in the Department of Pathology at the institution from November 2015 to October 2017. Fifty patients with an unhealthy cervix have undergone conventional Pap smears and histopathological biopsies with the suspicion of cervical malignancy or premalignancy attending the Obstetrics and Gynecology Outpatient Department. The obtained smears were arranged according to TBS. The tissue biopsies have been processed routinely and they are stained with hematoxylin and eosin for histopathological diagnosis. Furthermore, cases such as non-neoplastic, metastatic lesions, and recurrent cases were excluded from this study.

Results: The common age group has been identified as between 41 and 60 years and patients had low educational levels. Sensitivity, specificity, positive predictive value, negative predictive value, and diagnostic accuracy observed in this study were 89.28%, 63.63%, 64.1%, 72.72%, and 72% respectively.

Conclusion: Pap smear is a simple, effective, inexpensive procedure that can be routinely used as a screening tool for screening cervical cancer. TBSs also provide a standard approach for cytological evaluation that helps in the early detection of premalignant and malignant cervical lesions.

Downloads

Download data is not yet available.

References

Cervical Cancer. Available from: https://www.who.int/news-room/fact-sheets/detail/cervical-cancer [Last accessed on 2024 Jun 26].

Selvanayaki KM, Archana A. A comparative study of Pap smear cytology and histopathology of cervix biopsy. Trop J Pathol Microbiol. 2020;6(3):230-7.

Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359-86.

Alazzam M, Patterson A, Shafi M. Histologic and colposcopic correlation of cervical cytology showing? Glandular neoplasia. Arch Gynecol Obstet. 2010;281(4):703-7.

Thapa M. Cervical cancer awareness and practice of pap smear test among women with gynecological problems. JNMA J Nepal Med Assoc. 2018;56(211):654-7.

Moss EL, Taneja S, Munir F, Kent C, Robinson L, Potdar N, et al. Iatrogenic menopause after treatment for cervical cancer. Clin Oncol (R Coll Radiol). 2016;28(12):766-75.

Tuon FF, Bittencourt MS, Panichi MA, Pinto ÁP. Avaliação da sensibilidade e especificidade dos exames citopatológico e colposcópico em relação ao exame histológico na identificação de lesões intra-epiteliais cervicais. Rev Assoc Med Bras. 2002;48(2):140-4.

Jain V, Vyas A. Cervical neoplasia-cyto-histological correlation (Bethesda system) a study of 276 cases. J Cytol Histol. 2010;1(2):.

Gonzalez-Bosquet E, Almagro MM, Mora I, Suñol M, Callejo J, Lailla JM. Prevalence of human papilloma virus infection of the uterine cervix in women with abnormal cervical cytology. Eur J Gynaecol Oncol. 2006;27(2):135-8.

Rajaram S, Puthiya Kulap S, Gupta B, Arora VK, Bharti AC, Goel N. Evaluation of biomarkers p16/ki-67 in cervical cytology for diagnosis of cervical intraepithelial neoplasia. Indian J Gynecol Oncol. 2019;17(2):1-7.

Muhammad AW. Pap smear in early detection of cervical precancerous lesions in Erbil. Adv Med J. 2024;9(1):89-96.

Saha SS, Chowdhury RR, Mondal NR, Roy S, Sengupta S. Expression signatures of HOX cluster genes in cervical cancer pathogenesis: Impact of human papillomavirus type 16 oncoprotein E7. Oncotarget. 2017 May 30;8(22):36591-602.

Barut MU, Kale A, Kuyumcuoğlu U, Bozkurt M, Ağaçayak E, Özekinci S, et al. Analysis of sensitivity, specificity, and positive and negative predictive values of smear and colposcopy in diagnosis of premalignant and malignant cervical lesions. Med Sci Monit. 2015;21:3860-7.

Bamanikar S, Baravkar D, Chandanwale S, Dharwadkar A, Paranjape S. Study of cervical cytology and its correlation with clinical and histopathological findings. Clin Cancer Investig J. 2016;5(5):403.

Published

07-10-2024

How to Cite

GOURANGA CHARAN PRUSTY, RANJAN KUMAR MALLICK, GOUTAMI DAS NAYAK, SUNANDA NAYAK, CHANDRAPRAVA MISHRA, and TAPAS RANJAN MISHRA. “COMPARATIVE EVALUATION OF PAP SMEAR WITH HISTOPATHOLOGY IN CERVICAL LESION ACCORDING TO THE 2014 BETHESDA SYSTEM: AN INSTITUTIONAL STUDY”. Asian Journal of Pharmaceutical and Clinical Research, vol. 17, no. 10, Oct. 2024, pp. 67-71, doi:10.22159/ajpcr.2024v17i10.52700.

Issue

Section

Original Article(s)